AGREEMENTAgreement • October 17th, 2019 • Can-Fite BioPharma Ltd. • Pharmaceutical preparations
THIS AGREEMENT (the “Agreement”) effective as of the 7th day of October, 2019 (the “Commencement Date”), by and between Can-Fite Biopharma, Ltd. an Israeli company, whose address is 10 Bareket Street, Petach Tikva, Israel (the “Company”), and Capital Point Ltd., an Israeli company, whose address is 132 Menachem Begin Street, Tel Aviv, Israel (hereinafter referred to as “Capital”). Each of the Company and Capital shall also be referred to individually as a “Party” and collectively as the “Parties”.
Certain information in this document has been excluded pursuant to Regulation S-K, Item 601(b)(10). Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. Collaboration AgreementCollaboration Agreement • October 17th, 2019 • Can-Fite BioPharma Ltd. • Pharmaceutical preparations
This Collaboration Agreement (the “Agreement”) is made and entered into as of this 10 day of September, 2019 (the “Effective Date”) by and between Can-Fite Biopharma Ltd. an Israeli company, whose address is 10 Bareket Street, Petach Tikva, Israel (“Can-Fite”); Univo Pharmaceuticals Ltd. an Israeli company, whose address is 20 Ha’Harash street, Ashkelon, Israel (“Univo”) and UNV Medicine Ltd. an Israeli company, whose address is 20 Ha’Harash street, Ashkelon, Israel (“UNV”) (each a “Party” and collectively, the “Parties”).
